One in six Americans at some point during this year will go without health insurance. Most of them at any given point in time do not need it.
One in ten working Americans are without gainful employment right now. Every one of them wants a job . . . right now.
That as much as anything explains yesterday's Senate special election result in Massachusetts, the only state in the union that has a health insurance plan similar to ones passed in the House and Senate last year. Were voters there rejecting their own system? Not according to every poll that asks the question. The Bay State has the lowest uninsured rate in the nation; local residents have learned to participate in the insurance exchange set up under its plan (passed under a Republican governor); and people seem to like it.
So any commentary this morning that seeks to make health care reform the scapegoat for voters choosing Scott Brown, an obscure state senator, over an aloof attorney general Martha Coakley, is off the mark.
Massachusetts hasn't solved its health care problem. Its costs are still rising at an unsustainable pace, suggesting the reforms in the national legislation won't solve that problem either.
But moving beyond the insuring-the-uninsured has made cost control the central issue in that state, which it should be. Lower cost care will be better care, a fact that has been lost in the current debate. Reform as defined by the House and Senate bills has largely been about including everyone in a dysfunctional system that delivers poor quality care.
Reformers ultimately need to refocus the debate on the policy prescriptions that are needed to improve the quality of care and lower its cost. But to get to that point, they need to move beyond the question of universal coverage, as they did in Massachusetts.
Therefore, the Democrats who control Congress should do whatever is necessary to pass something that achieves that end. If it means getting the House to adopt the Senate bill, which is terribly flawed in many respects, especially in its embrace of schemes like taxing high-cost plans that falsely claim the magic of the market can hold down costs, so be it.
As numerous commentators pointed out this morning, both the House and Senate bills are centrist plans designed to win bipartisan support. Passage of either would require constant tinkering year after year to amend its flaws. Both rejected universal schemes that would eliminate employer-provided care: the left-backed single-payer plan or the everyone-buy-their-own plan proposed by Sen. Ron Wyden of Oregon, either of which makes more sense than the Rube Goldberg machine apparatus preferred by centrists.
So, given the political dynamic facing the Democratic leadership this morning, the best option is to have the House pass the Senate bill. And when the dust settles, probably after the next election, certainly after the economy has improved, the tinkering can begin.
Comments
"Massachusetts hasn't solved
"Massachusetts hasn't solved its health care problem. Its costs are still rising at an unsustainable pace, suggesting the reforms in the national legislation won't solve that problem either."
It's my understanding that that national plan has more cost controls in it than the MA plan did and so we have at least a shot at controlling costs with the national plan. Or maybe we have a shot at learning how to start controlling costs with the national plan.
PS - I'm not talking about
PS - I'm not talking about the excise tax when I mention cost controls in the Senate plan.
eRobin: All the sections of
eRobin: All the sections of the bills aimed at controlling costs involve Medicare, and many of those are pilot projects. Empowering the Medicare Payment Advisory Commission to impose efficiencies if health care inflation rises too fast was rejected, as was any form of negotiations over drug prices and reimportation. The biotechology industry was given a 12-year exclusivity period on data, which will needlessly delay the entry of follow-on biologics. Comparative effectiveness research was emasculated. The bills specifically prohibited agencies from using that research to say some technologies simply aren't worth the candle.
To be generous, there are a lot of arrows pointing at the destination of cost control, but few pathways for actually getting there. Still, I'd vote for the Senate bill if I were in the House. Even a third of a loaf is better than nothing. As a card carrying member of the middle class, I'm even willing to pay higher taxes to get people everyone insured, since only then will we be able to focus on the real problems with our health care system. But that puts me in the distinct minority known as fuzzy-headed liberals. A lot of people in the middle are struggling to pay their bills these days, and, based on the returns from Massachusetts, it would appear they're not feeling all that generous.